The Beachbody Company (BODY) Canaccord Genuity's 46th Annual Growth Conference summary
Event summary combining transcript, slides, and related documents.
Canaccord Genuity's 46th Annual Growth Conference summary
11 Aug, 2026Company history and turnaround
28-year-old business with over $12.5 billion in sales and 32 million users, operating in a $6.5 trillion health market.
Transitioned from infomercial and MLM to omni-channel, disbanding MLM in December 2024 and focusing on DTC and retail.
Headcount reduced from over 1,000 to under 300, with breakeven revenue lowered from $900 million to $160 million.
Achieved 11 consecutive quarters of positive adjusted EBITDA and significant debt reduction.
Financial turnaround completed a year ahead of schedule, enabling acceleration of innovation pipeline.
Product innovation and retail expansion
Launched 10-Minute BODi program targeting sedentary Americans and new P90X program after a decade.
Shakeology, with $3.7 billion in sales, expanded from DTC to retail, now in 131 Sprouts and 481 The Vitamin Shoppe stores.
Introduced new P90X and Insanity energy drinks, with test markets planned for late 2026.
Multi-channel strategy includes retail, DTC, and Amazon, with a pivot to prioritize nutrition in advertising.
Pipeline accelerated: new programs and products originally set for 2027 now launching throughout 2026.
Financial performance and strategic highlights
Free cash flow improved by $310 million, reaching $17.4 million in 2025.
Adjusted EBITDA improved by $116.9 million, with $76.5 million cumulative over 11 quarters.
Four consecutive quarters of positive net income, $32.4 million cash, and $25 million debt.
New lower-priced, smaller Shakeology format enables broader retail and online distribution.
Focus remains on fitness, nutrition, and wellness, avoiding low-margin physical equipment.
Latest events from The Beachbody Company
- Turnaround success drives profitability and innovation, with major retail launches in 2026.BODY
Investor presentation - Fourth straight quarter of profitability and strong margins despite a 22% revenue drop.BODY
Q2 2026 - Turnaround success, new retail launches, and digital innovation set the stage for 2026 growth.BODY
Sidoti's Year End Virtual Investor Conference - Turnaround completed ahead of schedule, with new products and retail expansion driving future growth.BODY
Sidoti Small-Cap Virtual Investor Conference - Turnaround success and retail expansion set the stage for accelerated growth in 2027.BODY
Noble Capital Markets June 2026 Emerging Growth Virtual Equity Conference - Turnaround success: multi-channel strategy, retail launches, and 10 straight profitable quarters.BODY
16th Annual LD Micro Invitational Conference - Third consecutive profitable quarter with $2.3M net income, margin gains, and retail expansion.BODY
Q1 2026 - First net income since IPO, improved margins, and ongoing liquidity risks.BODY
Q3 2025 - Gross margin rose to 67% as affiliate model pivot and restructuring narrowed net loss.BODY
Q3 2024